Analysis of ROMO1 Expression Levels and Its Oncogenic Role in Gastrointestinal Tract Cancers

Overview

Journal Curr Issues Mol Biol

Publisher MDPI

Specialty Molecular Biology

Date 2024 Dec 27

PMID 39727991

Authors

Selcuk Yaman

Osman Akidan

Mehmet Vatansever

Sema Misir

Serap Ozer Yaman

Affiliations

Soon will be listed here.

Abstract

Gastrointestinal tract cancers account for approximately one-third of cancer-related deaths. Early diagnosis and effective treatment are the most important ways to prevent cancer-related morbidity and mortality. ROMO1 has been shown to play an important role in many types of cancer. However, the biological function of ROMO1 is still poorly understood in gastrointestinal system cancers. The aim of this study is to reveal the expression change and oncogenic role of ROMO in gastrointestinal system cancers. Gene Expression Profiling Interactive Analysis (GEPIA), UALCAN, TIMER, GeneMANIA, TISIDB, and STRING were applied to assess the biological function of ROMO1 in gastrointestinal cancers (colon adenocarcinoma (COAD), esophageal carcinoma (ESCA), liver hepatocellular carcinoma (LIHC), pancreatic adenocarcinoma (PAAD), and stomach adenocarcinoma (STAD)). ROMO1 is significantly increased in COAD, ESCA, LUHC, and PAAD, and the overexpression of ROMO1 is associated with clinicopathological features. In addition, ROMO1 has been found to be closely associated with tumor-infiltrating immune cells in gastrointestinal cancers. ROMO1 is closely related to the inner mitochondrial membrane proteins (TIMM) family. The study revealed that ROMO1 is of significant clinical importance for gastrointestinal cancers and may have potential clinical utility in treatment and prognosis. Functional tests on cell lines derived from these particular gastrointestinal cancers can also be performed in vitro to evaluate the impact of the ROMO1 gene and other factors, like potential drugs, on the expression of these genes and the development and progression of the cancer.

References

Li T, Fan J, Wang B, Traugh N, Chen Q, Liu J . TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. Cancer Res. 2017; 77(21):e108-e110. PMC: 6042652. DOI: 10.1158/0008-5472.CAN-17-0307. View

Kim H, Jo M, Kim B, Kim J, Jeong Y, Na Y . Overexpression of Romo1 is an unfavorable prognostic biomarker and a predictor of lymphatic metastasis in non-small cell lung cancer patients. Onco Targets Ther. 2018; 11:4233-4246. PMC: 6061672. DOI: 10.2147/OTT.S161587. View

Lee S, Park Y, Chung J, Yoo Y . Romo1 and the NF-κB pathway are involved in oxidative stress-induced tumor cell invasion. Int J Oncol. 2015; 46(5):2021-8. DOI: 10.3892/ijo.2015.2889. View

Szklarczyk D, Franceschini A, Kuhn M, Simonovic M, Roth A, Minguez P . The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res. 2010; 39(Database issue):D561-8. PMC: 3013807. DOI: 10.1093/nar/gkq973. View

Yang Y, Zhang F, Huang H, Xie Z, Huang W, Xie H . Long noncoding RNA LINC00319 regulates ROMO1 expression and promotes bladder cancer progression via miR-4492/ROMO1 axis. J Cell Physiol. 2019; 235(4):3768-3775. DOI: 10.1002/jcp.29271. View

Norton M, Ng A, Baird S, Dumoulin A, Shutt T, Mah N . ROMO1 is an essential redox-dependent regulator of mitochondrial dynamics. Sci Signal. 2014; 7(310):ra10. DOI: 10.1126/scisignal.2004374. View

Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z . GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017; 45(W1):W98-W102. PMC: 5570223. DOI: 10.1093/nar/gkx247. View

Yu M, Song N, Park K, Park D, Kim S, Chae Y . Romo1 is associated with ROS production and cellular growth in human gliomas. J Neurooncol. 2014; 121(1):73-81. DOI: 10.1007/s11060-014-1608-x. View

Wadhwa V, Patel N, Grover D, Ali F, Thosani N . Interventional gastroenterology in oncology. CA Cancer J Clin. 2022; 73(3):286-319. DOI: 10.3322/caac.21766. View

10.

Ghasemi H, Amini M, Pegah A, Azizi E, Tayebinia H, Khanverdilou S . Overexpression of reactive oxygen species modulator 1 is associated with advanced grades of bladder cancer. Mol Biol Rep. 2020; 47(9):6497-6505. PMC: 7414271. DOI: 10.1007/s11033-020-05702-1. View

11.

Amini M, Karimi J, Khodadadi I, Tavilani H, Talebi S, Afshar B . Overexpression of ROMO1 and OMA1 are Potentially Biomarkers and Predict Unfavorable Prognosis in Gastric Cancer. J Gastrointest Cancer. 2019; 51(3):939-946. DOI: 10.1007/s12029-019-00330-w. View

12.

Amini M, Talebi S, Karimi J . Reactive Oxygen Species Modulator 1 (ROMO1), a New Potential Target for Cancer Diagnosis and Treatment. Chonnam Med J. 2019; 55(3):136-143. PMC: 6769249. DOI: 10.4068/cmj.2019.55.3.136. View

13.

Siegel R, Miller K, Fuchs H, Jemal A . Cancer statistics, 2022. CA Cancer J Clin. 2022; 72(1):7-33. DOI: 10.3322/caac.21708. View

14.

Chung J, Park S, Park S, Park E, Cha P, Kim B . Overexpression of Romo1 promotes production of reactive oxygen species and invasiveness of hepatic tumor cells. Gastroenterology. 2012; 143(4):1084-94.e7. DOI: 10.1053/j.gastro.2012.06.038. View

15.

Wang Z, Li S, Xu F, Fu J, Sun J, Gan X . ncRNAs-mediated high expression of TIMM8A correlates with poor prognosis and act as an oncogene in breast cancer. Cancer Cell Int. 2022; 22(1):177. PMC: 9063222. DOI: 10.1186/s12935-022-02595-x. View

16.

Na A, Chung Y, Lee S, Park S, Lee M, Yoo Y . A critical role for Romo1-derived ROS in cell proliferation. Biochem Biophys Res Commun. 2008; 369(2):672-8. DOI: 10.1016/j.bbrc.2008.02.098. View

17.

Lee S, Min J, Lee J, Kim C, Yoo Y, Lee E . Reactive oxygen species modulator 1 (Romo1) overexpression is an independent predictor of poor survival in NSCLC patients who undergo surgical resection. Lung Cancer. 2014; 87(1):45-52. DOI: 10.1016/j.lungcan.2014.11.004. View

18.

Martinez-Bernabe T, Pons D, Oliver J, Sastre-Serra J . Oxidative Phosphorylation as a Predictive Biomarker of Oxaliplatin Response in Colorectal Cancer. Biomolecules. 2024; 14(11). PMC: 11591675. DOI: 10.3390/biom14111359. View

19.

Kim I, Kim S, Kim H, Kim J, Lee J, Choi S . Disturbance of DKK1 level is partly involved in survival of lung cancer cells via regulation of ROMO1 and γ-radiation sensitivity. Biochem Biophys Res Commun. 2013; 443(1):49-55. DOI: 10.1016/j.bbrc.2013.11.038. View

20.

Sun G, Cao Y, Qian C, Wan Z, Zhu J, Guo J . Romo1 is involved in the immune response of glioblastoma by regulating the function of macrophages. Aging (Albany NY). 2020; 12(2):1114-1127. PMC: 7053633. DOI: 10.18632/aging.102648. View